Skip to content

Study · Not a test of the peptide alone · 2012

2 results

Perfusable branching microvessel bed for vascularization of engineered tissues.

Chiu LL, Montgomery M, Liang Y, Liu H, Radisic M

Proceedings of the National Academy of Sciences of the United States of America26 Nov 2012Cited by 121 (Europe PMC)

PMID23184971 (opens in a new tab)PMCIDPMC3528595 (opens in a new tab)DOI10.1073/pnas.1210580109 (opens in a new tab)PepBankPUB-23184971
Source linkPubMedAsk about this study
Jump to 2 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study2

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone2

In this study, Thymosin beta-4 (human) was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Thymosin beta-4 (human).

  1. 01LabNot a test of Thymosin beta-4 (human) aloneEx vivo tissueOther

    In vascular explants on micropatterned thymosin beta‑4 hydrogel, capillary outgrowths connected between the parent explants by day 21.

    In plain wordsIn the lab, blood vessel sprouts grown on a patterned gel containing Tβ4 connected between tissue pieces by day 21.

    Peptide
    Thymosin beta-4 (human)
    Outcome
    Not applicableCapillary outgrowth connection between explants
    Study

    n: not reported in source

    vascular explants on micropatterned thymosin β4-hydrogel substrates
    Outcome group
    Angiogenesis · Cardiovascular

    Source sentences

    Summary
    The capillary outgrowths connected between the parent explants by day 21
    1 context sentence
    Summary · context
    The network was generated by inducing directed capillary sprouting from vascular explants on micropatterned substrates containing thymosin β4-hydrogel.

    In this study, Thymosin beta-4 (human) was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Thymosin beta-4 (human).

  2. 02LabNot a test of Thymosin beta-4 (human) aloneEx vivo tissueOther

    In vascular explants on thymosin beta‑4 hydrogel, soluble VEGF and hepatocyte growth factor accelerated the connection of capillary outgrowths to 14 days.

    In plain wordsIn lab tests, adding VEGF and HGF to the thymosin beta‑4 gel sped up vessel connection to 14 days.

    Peptide
    Thymosin beta-4 (human)
    Outcome
    IncreaseSpeed of capillary connection with VEGF and HGF
    Study

    n: not reported in source

    vascular explants on micropatterned thymosin β4-hydrogel substrates
    Outcome group
    Angiogenesis · Cardiovascular

    Source sentences

    Summary
    The capillary outgrowths connected between the parent explants by day 21, a process that was accelerated to 14 d by application of soluble VEGF and hepatocyte growth factor.
    1 context sentence
    Summary · context
    The network was generated by inducing directed capillary sprouting from vascular explants on micropatterned substrates containing thymosin β4-hydrogel.

    In this study, Thymosin beta-4 (human) was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Thymosin beta-4 (human).

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    13 Oct 2026, 01:52 UTC

    Study results updated

  2. Version 1

    12 Oct 2026, 18:17 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.